{"id":"W2014836885","doi":"10.1111/tbj.12284","title":"Trastuzumab Beyond Progression for HER2 Positive Metastatic Breast Cancer: Progression-Free Survival on First-Line Therapy Predicts Overall Survival Impact","year":2014,"lang":"en","type":"article","venue":"The Breast Journal","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Cancer Foundation; Cancer Care Nova Scotia; Queen Elizabeth II Health Sciences Centre","funders":"Roche Canada","keywords":"Medicine; Trastuzumab; Internal medicine; Metastatic breast cancer; Oncology; Docetaxel; Breast cancer; Chemotherapy; Retrospective cohort study; Paclitaxel; Cohort; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001681434,0.0001402665,0.0003972869,0.0006253106,0.0001230218,0.0006341197,0.0002729534,0.0002496435,0.0009819611],"category_scores_gemma":[0.005375589,0.00009873806,0.0006348808,0.0006666064,0.0001881496,0.0005016018,0.0002466125,0.0004363683,0.0001846083],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003718625,"about_ca_system_score_gemma":0.000260272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009899226,"about_ca_topic_score_gemma":0.002456222,"domain_scores_codex":[0.9993665,0.0002668987,0.00007833575,0.00008972934,0.0001355542,0.00006295896],"domain_scores_gemma":[0.9955361,0.002091018,0.001682901,0.0001596826,0.0002801841,0.0002500429],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005049956,0.00001422367,0.9841263,0.00005601449,0.000117659,0.0001430679,0.00002966176,0.0001250973,0.0003143772,0.00002302233,0.0001479951,0.01439765],"study_design_scores_gemma":[0.00001532854,0.000197594,0.9973987,0.00003185018,0.0002103774,0.0008873463,0.00004353706,0.0003959659,0.0001857839,0.00004508933,0.0005846669,0.000003744004],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846529,0.0133777,0.00024534,0.0001872222,0.00001235413,0.00001010638,0.0004269837,0.000006194851,0.001081196],"genre_scores_gemma":[0.9982907,0.001178626,0.00008455931,0.00003362216,0.00003964829,0.000003592716,0.000260357,0.000002006521,0.0001068744],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001681434,"threshold_uncertainty_score":0.008892357,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03977329334124006,"score_gpt":0.3970839875597167,"score_spread":0.3573106942184766,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}